ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Q&A

Q&A

In this interview we discuss the issue of burnout in oncology, including signs and risk factors, how it might affect patient care, and strategies for prevention.

In this interview we discuss the ASCO provisional clinical opinion on second-line hormonal therapy for chemotherapy-naive castration-resistant prostate cancer.

In this interview we discuss the goals of the Community Oncology Alliance, highlights from their annual meeting, and the challenge of transitioning cancer care to the hospital setting.

In this interview we discuss new data on the use of radiotherapy in cancer patients with brain metastases.

In this interview we discuss the effect of the gut microbiome on responses and survival outcomes in metastatic melanoma patients treated with anti–PD-1 immunotherapies.

In this interview we discuss some of the novel therapeutics in development for HER2-amplified breast cancer.

In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.

Pages

Subscribe to Q&A on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.